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2,7-Diazabicyclo[2.2.1]heptanes: novel asymmetric
access and controlled bridge-opening†
Gary R. Peczkowski,a Philip G. E. Craven, a Darren Steadb and
Nigel S. Simpkins *a
Organocatalysed asymmetric Michael additions of substituted tri-
ketopiperazines to enones aﬀord products in high yield and enantio-
meric ratio (er). Further modification delivers products possessing
natural product (NP) scaﬀolds including diazabicyclo[2.2.1]heptane,
prolinamide and harmicine.
For many years natural products have provided organic chemists
with amultitude of synthetically challenging architectures, providing
the stimulus for the development of new synthetic methods and
strategies. An additional driving force in this field is provided by the
diverse biological activities inherent in many natural products. The
fact that around 30% of small molecule drugs developed in the last
30 years are either natural products, or their close relatives, is ample
testament to the significance of this area.1,2
Traditionally, natural product synthesis is the exploration of
a route towards a singular target compound3 and with rapid
access in mind, many research groups compete for the shortest
linear sequence.4,5 However, this approach often overlooks any
potentially rewarding analogues or family members.6 Therefore,
a route in which multiple interesting scaﬀolds may be accessed
from a common motif is highly desirable.7,8
In this report we describe how our newly developed asym-
metric access to triketopiperazines (TKPs) can be utilised in this
way to gain access to several interesting natural product-like
motifs, as illustrated in Scheme 1.
We conceived that structures including various diazabicyclo-
[2.2.1]heptane core structures and proline amides would be
available via initial asymmetric Michael addition of a TKP, followed
by TKP manipulations involving ring-opening. The diazabicyclo-
[2.2.1]heptane structures are especially interesting as core com-
ponents of biologically active products as shown in Fig. 1.9–15
Recent reports from our group have described highly enantio-
selective Michael addition chemistry of various substituted TKP
systems.16–18 The chiral TKPs are generated in highly diastereo- and
enantioselective form, and are amenable to fruitful regioselective
manipulation to give attractive natural product like structures.
In the present research we opted to employ novel TKP structures
in which R = a-aryl and a-heteroaryl, in order to achieve the
objectives shown in Scheme 1. Initially, a-aryl TKPs 1a–j were
readily prepared using previously established methods.16,18–24
All optimisation was conducted with phenyl TKP 1a employing
methyl vinyl ketone (MVK) as the Michael acceptor (for details
see ESI†).25 Under the optimised conditions, using the O-benzylated
cinchona derived catalyst 3, the Michael additions of a-aryl TKPs
Scheme 1 Michael addition-rearrangement strategy towards NP scaﬀolds.
Fig. 1 NPs containing the diazabicyclo[2.2.1]heptane motif.
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1a–j to MVK were explored and the results are shown in Table 1
(entries 1–10).
Addition products 2a–j were isolated in good to excellent
yields albeit with mixed levels of enantioselectivity. High levels
of enantioselectivity were observed for substrates possessing
either phenyl, p-substituted phenyl or unsubstituted 5-membered
heterocycles (entries 1–6). Erosion of enantioselectivity appears to
be the result of increased steric requirement proximal to the
reacting enolate centre, e.g. with o-substituted aryl substrates
(entries 7 and 8). This is exemplified by two N-Me pyrrole
analogues (entries 8 and 9) in which moving the N-methyl group
away from the reactive centre results in a significant increase in
enantioselectivity.
When these conditions were employed with alternative enone
acceptors, varied results were obtained (entries 11–17). Enantio-
selectivities remained high when employing ethyl vinyl ketone
(entries 11–13) while amarked reduction in selectivity was observed
with the use of phenyl vinyl ketone (entries 14 and 15) with the
exception of entry 16 at 96 :4 er. Selectivity was vastly reduced when
using acrolein as theMichael acceptor, even when the reaction was
performed at lower temperature (entry 17).
Following crystallisation, the absolute configuration of adduct
2f, generated from reaction of TKP 1f with MVK, was determined
by X-ray crystallography (Fig. 2A).26
Our results are in accordance with the stereochemical model
originally proposed by Deng for the dual activation and
co-ordination, by the catalyst, of both the nucleophile and the
electrophile, and with our group’s previous works (Fig. 2B).16,17,27
With the Michael addition products 2 in hand, our attention
turned to the removal of the oxalyl unit in an attempt to free the
quaternary a-amino acid. It was envisioned that the use of a
dinucleophile would achieve this goal through initial attack at
the highly electrophilic C-3 carbonyl and subsequent cyclisation
onto the neighbouring carbonyl.16 After investigating a range of
dinucleophiles, it was found that ethanolamine removed the
oxalyl component, however, the free aminoamide was not isolated.
Instead, direct access to products that possess the diazabicyclo-
[2.2.1]heptane (4) core framework was achieved, Table 2.
This process involves release of the TKP ring nitrogen functions
from the oxalyl unit, and their convergent condensation with the
ketone originating from the Michael acceptor to form an unusual
bridged N-acyl aminal structure. Moderate to high yields were
observed in most cases (entries 1–6, 11 and 12) with the exception
Table 1 Michael additions of TKPs 1a–j mediated by catalyst 3
Entry TKP Ar R 2 (%) er
1 1a Ph Me 2a 90 92 : 8
2 1b p-C6H4OMe Me 2b 83 93 : 7
3 1c p-C6H4NO2 Me 2c 70 95 : 5
4 1d p-C6H4Br Me 2d 88 91 : 9
5 1e Furan-2-yl Me 2e 99 94 : 6
6 1f Thiophen-2-yl Me 2f 93 94 : 6
7 1g o-C6H4Br Me 2g 88 55 : 44
8 1h N-Methylpyrrol-2-yl Me 2h 99 50 : 50
9 1i N-Methylpyrrol-3-yl Me 2i 63 77 : 23
10 1j Indol-3-yl Me 2j 91 73 : 27
11 1a Ph Et 2k 91 96 : 4
12 1b p-C6H4OMe Et 2l 75 97 : 3
13 1c p-C6H4NO2 Et 2m 63 97 : 3
14 1a Ph Ph 2n 90 85 : 15
15 1b p-C6H4OMe Ph 2o 95 87 : 13
16 1c p-C6H4NO2 Ph 2p 88 96 : 4
17 1a Ph H 2q 85 58 : 42a,b
a 30 1C, 12 days. b HPLC conducted on the acetal derivative.
Fig. 2 (A) Crystal structure of 2fwith ellipsoids drawn at the 50% probability
level. The thiophene ring is disordered over two positions, which is the result
of rotation around the C6–C15 bond, at a refined percentage occupancy
ratio of 63.9(3) : 36.1(3), only the major position is shown for clarity. (B) Model
for 3-catalysed Michael addition generating 2f.
Table 2 Rearrangement of adducts 2 to diazabicyclo[2.2.1]heptanes 4a–m
Entry TKP Ar R 4 (%)
1 2a Ph Me 4a 87a
2 2b p-C6H4OMe Me 4b 51
3 2c p-C6H4NO2 Me 4c 61
4 2d p-C6H4Br Me 4d 60
5 2e Furan-2-yl Me 4e 75
6 2f Thiophen-2-yl Me 4f 50a
7 2g o-C6H4Br Me 4g 29
8 2h N-Methylpyrrol-2-yl Me 4h 26
9 2i N-Methylpyrrol-3-yl Me 4i 25
10 2j Indol-3-yl Me 4j 21
11 2k Ph Et 4k 50
12 2n Ph Ph 4l 84
13 2q Ph H 4m 28
a Enantioenriched substrates retain enantiopurity.
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of substrates bearing o-substituents (entries 7–10) and the acrolein
adduct (entry 13). As expected, the conversion of enantioenriched
substrates proceeded with retention of enantiopurity, as demon-
strated for entries 1 and 6. The structure of 4a was unequivocally
confirmed by single crystal X-ray analysis (Fig. 3).28
With diazabicycle 4a in hand, we endeavoured to break
open the newly formed cyclic aminal to reveal a quaternary
2,5-disubstituted prolinamide. Several previously described
reductive ring opening conditions were examined and details
can be found in the ESI.† 29–31
Reduction of diazabicycle 4a with DIBAL at 78 1C aﬀords
prolinamides 5a and 5b in a modest 6.5 : 1 dr with a combined
yield of 57% (Scheme 2).
Interestingly, the putative intermediate iminium ion involved in
the process can be isolated in the form of 6 by treatment of
diazabicycle 4awith HCl in dioxane. Preliminary investigations have
found that this also undergoes reduction to give prolinamides 5a + b
(Scheme 3).
The potential to access further natural product skeletons
was investigated by intramolecular trapping of the iminium
intermediate. Thus, diazabicycle 9 was synthesised from TKP 7
using our optimised methodology (Scheme 4). Treatment of 9
with HCl instigated a Pictet–Spengler reaction to yield product
10, as a single isomer, which possesses the scaffold of the
natural product harmicine.32,33
In conclusion, we have demonstrated that a-aryl TKPs can
undergo asymmetric Michael additions with high selectivity and
that manipulation of the TKP motif allows access to multiple
products possessing NP scaﬀolds. We anticipate that additional
biologically relevant and NP scaﬀolds can be accessed and
investigations are currently on-going within our laboratory to
unlock the further potential of the TKP motif.
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